Literature DB >> 34709449

Trial of labor after cesarean in primiparous women with fetal macrosomia.

Naama Lessans1, Stav Martonovits2, Misgav Rottenstreich3, Simcha Yagel1, Geffen Kleinstern4, Hen Y Sela3, Shay Porat1, Gabriel Levin1, Joshua I Rosenbloom1, Yosef Ezra1, Amihai Rottenstreich5.   

Abstract

KEY MESSAGE: Spontaneous labor onset, epidural anesthesia and prior cesarean for non-arrest disorders are strong predictors of successful vaginal birth after cesarean in women delivering a macrosomic fetus.
PURPOSE: Lower rates of successful vaginal birth after cesarean in association with increasing birthweight were previously reported. We aimed to determine the factors associated with successful trial of labor after cesarean (TOLAC) among primiparous women with fetal macrosomia.
METHODS: A retrospective cohort study conducted during 2005-2019 at two university hospitals, including all primiparous women delivering a singleton fetus weighing ≥ 4000 g, after cesarean delivery at their first delivery. A multivariate analysis was performed to evaluate the characteristics associated with TOLAC success (primary outcome).
RESULTS: Of 551 primiparous women who met the inclusion criteria, 50.1% (n = 276) attempted a TOLAC and 174 (63.0%) successfully delivered vaginally. In a multivariate analysis, spontaneous onset of labor (aOR [95% CI] 3.68 (2.05, 6.61), P < 0.001), epidural anesthesia (aOR [95% CI] 2.38 (1.35, 4.20), P = 0.003) and history of cesarean delivery due to non-arrest disorder (aOR [95% CI] 2.25 (1.32, 3.85), P = 0.003) were the only independent factors associated with TOLAC success. Successful TOLAC was achieved in 82.0% (82/100) in the presence of all three favorable factors, 61.3% (65/106) in the presence of two factors and 38.6% (27/70) in the presence of one or less of these three factors (P < 0.001).
CONCLUSION: Spontaneous onset of labor, epidural anesthesia and prior cesarean delivery due to non-arrest disorders were independently associated with higher vaginal birth after cesarean rate among women with fetal macrosomia, with an overall favorable success rate in the presence of these factors. These findings should be implemented in patient counseling in those contemplating a vaginal birth in this setting.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Birthweight; Cesarean delivery; Macrosomia; Predictors; Trial of labor; Vaginal birth

Mesh:

Year:  2021        PMID: 34709449     DOI: 10.1007/s00404-021-06312-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.493


  4 in total

1.  Trial of labor after 40 weeks' gestation in women with prior cesarean.

Authors:  C M Zelop; T D Shipp; A Cohen; J T Repke; E Lieberman
Journal:  Obstet Gynecol       Date:  2001-03       Impact factor: 7.661

2.  Real-time data analysis using a machine learning model significantly improves prediction of successful vaginal deliveries.

Authors:  Joshua Guedalia; Michal Lipschuetz; Michal Novoselsky-Persky; Sarah M Cohen; Amihai Rottenstreich; Gabriel Levin; Simcha Yagel; Ron Unger; Yishai Sompolinsky
Journal:  Am J Obstet Gynecol       Date:  2020-05-17       Impact factor: 8.661

3.  Vaginal birth after cesarean section: is suspected fetal macrosomia a contraindication?

Authors:  B L Flamm; J R Goings
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

4.  Previous cesarean birth. Trial of labor in women with macrosomic infants.

Authors:  J P Phelan; G S Eglinton; J M Horenstein; S L Clark; S Yeh
Journal:  J Reprod Med       Date:  1984-01       Impact factor: 0.142

  4 in total
  2 in total

1.  Trial of labor after cesarean in women with hypertensive disorders and no prior vaginal delivery.

Authors:  Gabriel Levin; Abraham Tsur; Lee Tenenbaum; Nizan Mor; Michal Zamir; Raanan Meyer
Journal:  Arch Gynecol Obstet       Date:  2022-05-16       Impact factor: 2.344

2.  Sonographic fetal head circumference is associated with trial of labor after cesarean section success.

Authors:  Raanan Meyer; Abraham Tsur; Lee Tenenbaum; Nizan Mor; Michal Zamir; Gabriel Levin
Journal:  Arch Gynecol Obstet       Date:  2022-03-02       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.